Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy

2010 ◽  
Vol 29 (6) ◽  
pp. 616-624 ◽  
Author(s):  
Mark S. Slaughter ◽  
Yoshifumi Naka ◽  
Ranjit John ◽  
Andrew Boyle ◽  
John V. Conte ◽  
...  
2010 ◽  
Vol 74 (4) ◽  
pp. 715-722 ◽  
Author(s):  
Shunsuke Saito ◽  
Goro Matsumiya ◽  
Taichi Sakaguchi ◽  
Shigeru Miyagawa ◽  
Yasushi Yoshikawa ◽  
...  

1995 ◽  
Vol 222 (3) ◽  
pp. 327-338 ◽  
Author(s):  
O. H. Frazier ◽  
Eric A. Rose ◽  
Patrick McCarthy ◽  
Nelson A. Burton ◽  
Alfred Tector ◽  
...  

1983 ◽  
Vol 7 (1) ◽  
pp. 64-73 ◽  
Author(s):  
John C. Norman ◽  
Michael G. McGee ◽  
John M. Fuqua ◽  
Stephen R. Igo ◽  
Stephen A. Turner ◽  
...  

2017 ◽  
Vol 44 (2) ◽  
pp. 141-143 ◽  
Author(s):  
Andrew C.W. Baldwin ◽  
Elena Sandoval ◽  
William E. Cohn ◽  
Hari R. Mallidi ◽  
Jeffrey A. Morgan ◽  
...  

Although biventricular heart failure has been successfully managed with dual continuous-flow ventricular assist devices, the long-term use of 2 mechanically dissimilar pumps has traditionally been discouraged. We present the case of a 52-year-old man whose treatment with a HeartMate II left ventricular assist device was complicated by right ventricular failure, necessitating the implantation of a long-term right ventricular assist device. A HeartWare left ventricular assist device was placed along the right ventricular base to avoid interference with the HeartMate II housing. The patient was discharged from the hospital after routine postoperative care and dual-device training. This case shows that, despite logistical complexities, nonidentical continuous-flow device pairings can successfully provide long-term biventricular support.


1991 ◽  
Vol 2 (3) ◽  
pp. 575-586 ◽  
Author(s):  
Julie A. Shinn

Clinical investigation of the Novacor ventricular assist system has been ongoing since 1984. Major successes have been achieved using the device as a bridge to heart transplant. This system uses an electrically driven, pulsatile pump implanted in the left upper abdominal quadrant. The system has demonstrated the ability to provide long-term patient support, a feature that allows patients to become mobile and active once recovered from their initial heart failure. By the time of transplant, nutrition is restored, activity tolerance is improved, and most patients require no inotropic support. The system allows patients to recover from cardiogenic shock by providing total systemic circulatory support


Sign in / Sign up

Export Citation Format

Share Document